" Very fortunate that outgoings of this Company are not on par with biotech or oilers, this Company would have been long gone. "
More cost-intensive projects are also possible, Anteo has always gone it alone.
This can also work if you can raise money on favourable terms.
I would have no problem with a cr of AUD 20 or 30 million if the issue price - as in 2021 - was 26 cents.
There would also be the possibility of realising a large project, such as EuGeni, with a strategic partner.
With a good name on Anteo's side and cost splitting, there might be an excellent Covid test on the market today. This gap has still not been filled.
If I understood David's answer to Richard's question correctly, then the doors to the ‘old’ partners such as Merck, ThermoFisher, Bangs, Luminex are open again due to an improved data situation.
This could lead to such partnerships.
Add to My Watchlist
What is My Watchlist?
